TMO Thermo Fisher Scientific Inc. logo

TMO Thermo Fisher Scientific Inc.

Healthcare
$448.28-0.24%ClosedMarket Cap: $166.59B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

27.08

PEG

4.53

P/B

3.21

P/S

3.69

EV/EBITDA

18.50

DCF Value

$540.72

FCF Yield

4.1%

Div Yield

0.4%

Margins & Returns

Gross Margin

39.4%

Operating Margin

17.8%

Net Margin

15.2%

ROE

13.3%

ROA

6.1%

ROIC

7.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$11.01B$1.65B$
Q4 null$12.21B$1.98B$
FY null$44.56B$6.74B$
Q3 null$11.12B$1.62B$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$638.20

Target (Median)

$644.50

Target Range

$490.00 - $750.00

5 Strong Buy19 Buy3 Hold0 Sell0 Strong Sell
Wells FargoOverweight
2026-05-08
BairdOutperform
2026-04-24
StifelBuy
2026-04-24
BarclaysOverweight
2026-04-14
Evercore ISI GroupOutperform
2026-04-06

Trading Activity

Insider Trades

View All
WEISLER DION Jdirector
SellFri May 22
WEISLER DION Jdirector
SellFri May 22
SPERLING SCOTT Mdirector
SellFri May 22
Spar Debora Ldirector
SellFri May 22
Lynch Karen Sdirector
SellFri May 22

Congress Trades

View All
Dwight EvansSell
Mon May 18
Dwight EvansSell
Fri May 15
Ro KhannaBuy
Wed May 13
Ro KhannaBuy
Thu Apr 09

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

Beta

0.88

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Peers